Niemann-Pick C disease: Cholesterol handling gone awry

Molecular Medicine Today

Volumn 4, Issue 12, 1998, Pages 525-531

  Morris, Jill A ^a   Carstea, Eugene D ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b St Mary's Hospital Grand Junction   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL TRANSPORT; HUMAN; INTRACELLULAR TRANSPORT; NIEMANN PICK DISEASE; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; LIPOPROTEINS, LDL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NIEMANN-PICK DISEASES; PROTEINS;

EID: 0031742639     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01374-4     Document Type: Review

References (49)

1. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
2. Assmann, G. and Seedorf, U. (1995) Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease, in The Metabolic and Molecular Bases of Inherited Disease (7th edn) (Scriver, C.R. et al., eds), pp. 2563-2587, McGraw-Hill.
3. Pentchev, P.G. et al. (1995) Niemann-Pick disease type C: a cellular cholesterol lipidosis, in The Metabolic and Molecular Bases of Inherited Disease (7th edn) (Scriver, C.R. et al., eds), pp. 2625-2639, McGraw-Hill.
4. Liscum L., Ruggiero R.M., Faust J.R. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J. Cell Biol. 108:1989;1625-1636.
5. Morris M.D.et al. Lysosome lipid storage disorder in NCTR-BALB/c mice. I. Description of the disease and genetics. Am. J. Pathol. 108:1982;140-149.
6. Shio H.et al. Lysosome lipid storage disorder in NCTR-BALB/c mice. II. Morphologic and cytochemical studies. Am. J. Pathol. 108:1982;150-159.
7. Pentchev P.G.et al. The cholesterol storage disorder of the mutant BALB/c mouse. A primary genetic lesion closely linked to defective esterification of exogenously derived cholesterol and its relationship to human type C Niemann-Pick disease. J. Biol. Chem. 261:1986;2772-2777.
8. Pentchev P.G.et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl. Acad. Sci. U. S. A. 82:1985;8247-8251.
9. Sokol J.et al. Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. J. Biol. Chem. 263:1988;3411-3417.
10. Blanchette-Mackie E.J.et al. Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc. Natl. Acad. Sci. U. S. A. 85:1988;8022-8026.
11. Pentchev P.G.et al. Group C Niemann-Pick disease: faulty regulation of low-density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J. 1:1987;40-45.
12. Pentchev P.G.et al. The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol. Biochim. Biophys. Acta. 1225:1994;235-243.
13. Carstea E.D.et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 277:1997;228-231.
14. Loftus S.K.et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277:1997;232-235.
15. Fink J.R.et al. Clinical spectrum of Niemann-Pick disease type C. Neurology. 39:1989;1040-1049.
16. Higgins J.J.et al. A clinical staging classification for type C Niemann-Pick disease. Neurology. 42:1992;2286-2290.
17. Winsor E.J.T., Welch J.P. Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D). Am. J. Hum. Genet. 30:1978;530-538.
18. 3097>T transversion in NPC1. Am. J. Hum. Genet. 63:1998;52-54.
19. Neufeld E.B.et al. Intracellular trafficking of cholesterol monitored with a cyclodextrin. J. Biol. Chem. 271:1996;21604-21613.
20. Byers D.M.et al. Niemann-Pick Type II fibroblasts exhibit impaired cholesterol esterification in response to sphingomyelin hydrolysis. Biochim. Biophys. Acta. 1138:1992;20-26.
21. Spillane D.M.et al. Translocation of both lysosomal LDL-derived cholesterol and plasma membrane cholesterol to the endoplasmic reticulum for esterification may require common cellular factors involved in cholesterol egress from the acidic compartments (lysosomes/endosomes). Biochim. Biophys. Acta. 1254:1995;283-294.
22. Coxey R.A.et al. Differential accumulation of cholesterol in Golgi compartments of normal and Niemann-Pick type C fibroblasts incubated with LDL: a cytochemical freeze-fracture study. J. Lipid Res. 34:1993;1165-1176.
23. Shamburek R.D.et al. Intracellular trafficking of the free cholesterol derived from LDL cholesteryl ester is defective in vivo in Niemann-Pick C disease: insights on normal metabolism of HDL and LDL gained from the NPC mutation. Lipid Res. 38:1997;2422-2435.
24. Gartner J.C.et al. Progression of neurovisceral storage disease with supranuclear opthalmoplegia following orthotopic liver transplantation. Pediatrics. 77:1986;104-106.
25. Hashimoto K.et al. A case of type C Niemann-Pick disease. No To Hattatsu. 22:1990;381-385.
26. Patterson M.C.et al. The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology. 43:1993;61-64.
27. Sylvain M.et al. Magnetic resonance spectroscopy in Niemann-Pick disease type C: Correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr. Neurol. 10:1994;228-232.
28. Miyawaki S.et al. Sphingomyelinosis, a new mutation in the mouse: A model of Niemann-Pick disease in humans. J. Hered. 73:1982;257-263.
29. Lowenthal A.C.et al. Feline sphingolipidosis resembling Niemann-Pick disease type C. Acta Neuropathol. 81:1990;189-197.
30. Ohno K.et al. A cell line derived from sphingomyelinosis mouse shows alterations in intracellular cholesterol metabolism similar to those in type C Niemann-Pick disease. Cell Struct. Funct. 17:1992;229-235.
31. Sakai Y.et al. A molecular genetic linkage map of mouse chromosome 18, including spm, Grl-1, Fim-2/c-fms and mbp. Biochem. Genet. 29:1991;103-113.
32. Yamamoto T.et al. A possible same genetic defect in two Niemann-Pick disease model in mice. No To Hattatsu. 26:1994;318-322.
33. Higashi, Y. et al. (1991) Pathology of Niemann-Pick type C: studies of murine mutants, in Neuropathology in Brain Research (Ikuta, F., ed.), pp. 85-102, Elsevier Science.
34. Elleder M.et al. Niemann-Pick disease type C: study on the nature of the cerebral storage process. Acta Neuropathol. 66:1985;325-336.
35. March P.A.et al. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol. 94:1997;164-172.
36. Walkley S.U. Pyramidal neurons with ectopic dendrites in storage diseases exhibit incrased GM2 ganglioside immunoreactivity. Neuroscience. 384:1995;1027-1035.
37. Sato M.et al. Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C. Brain Dev. 20:1998;50-52.
38. Watanabe Y.et al. Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann-Pick disease type C. Brain Dev. 20:1998;95-97.
39. Goodrum J.F., Pentchev P.G. Cholesterol reutilization during myelination of regenerating PNS axons is impaired in Niemann-Pick disease type C mice. J. Neurosci. Res. 49:1997;389-392.
40. Pentchev P.G.et al. A genetic storage disorder in Balb/c mice with a metabolic block in esterification of exogenous cholesterol. J. Biol. Chem. 259:1984;5784-5791.
41. Liscum L., Faust J.R. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2(diethylamino)ethoxy]androst-5-en-17-one. J. Biol. Chem. 264:1989;11796-11806.
42. Rodriquez-Lafrasse C.et al. Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. Biochim. Biophys. Acta. 1043:1990;123-128.
43. Roff C.et al. Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev. Neurosci. 13:1991;315-319.
44. Butler J.D.et al. Progesterone blocks cholesterol translocation from lysosomes. J. Biol. Chem. 33:1992;23797-23805.
45. Carstea E.D.et al. Localizing the Niemann-Pick C gene to 18q11-12. Am. J. Hum. Genet. 55:1994;182.
46. 476, contained in the extended carboxyl cytoplasmic tail, are critical for targeting of the resident lysosomal membrane protein LIMP II to lysosomes. J. Biol. Chem. 269:1994;6622-6631.
47. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:1997;331-340.
48. Steinberg S.J., Ward C.P., Fensom A.H. Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. J. Med. Genet. 31:1994;317-320.
49. Vanier M.T.et al. Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. Am. J. Hum. Genet. 58:1996;118-125.